Prime Medicine Inc (PRME)

Finanzdaten der Prime Medicine Inc-Aktie (PRME)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.591	-	-	-	-
Operating Expenses	28.09% 48.93	68.04	51.46	45.26	40.03
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	48.93	-	-	-	-
Operating Income/Loss	28.96% -48.34	-68.04	-51.46	-45.26	-40.03
Nonoperating Income/Loss	13.08% 2.714	2.40	0.643	2.903	0.434
Income/Loss From Continuing Operations Before Tax	100.90% 0.591	-65.64	-50.82	-42.38	-39.40
Income Tax Expense/Benefit, Deferred	0.134	-	-0.108	0.031	-0.202
Income Tax Expense/Benefit	0.134	-	-0.108	0.031	-0.202
Income/Loss From Continuing Operations After Tax	30.29% -45.76	-65.64	-50.71	-42.38	-39.40
Net Income/Loss	30.29% -45.76	-65.64	-50.71	-42.38	-39.40
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	20,816% 104.47	0.4995	91.85	90.47	89.06
Diluted Average Shares	20,816% 104.47	0.4995	91.85	90.47	89.06
Basic Earnings Per Share	38.89% -0.44	-0.72	-0.55	-0.47	-0.44
Diluted Earnings Per Share	38.89% -0.44	-0.72	-0.55	-0.47	-0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-